FEASIBILITY OF DIRECT SOLID SAMPLING FOR ARSENIC DETERMINATION IN SULFUR-CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS BY GF AAS

Bibliographic Details
Title: FEASIBILITY OF DIRECT SOLID SAMPLING FOR ARSENIC DETERMINATION IN SULFUR-CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS BY GF AAS
Authors: Erico Marlon Moraes Flores, Fabio Andrei Duarte, Gabriel Toneto Druzian, Mariele Samuel Nascimento, Juliano Smanioto Barin, Rodrigo Cordeiro Bolzan
Source: Drug Analytical Research, Vol 3, Iss 1, Pp 2-9 (2019)
Publisher Information: Universidade Federal do Rio Grande do Sul, 2019.
Publication Year: 2019
Collection: LCC:Biotechnology
LCC:Chemistry
Subject Terms: arsenic determination, solid sampling, graphite furnace atomic absorption spectrometry, elemental impurities determination, toxic elements, Biotechnology, TP248.13-248.65, Chemistry, QD1-999
More Details: A method for As determination in sulfur-containing active pharmaceutical ingredients (SC-APIs) by direct solid sampling graphite furnace atomic absorption (DSS-GF AAS) was developed. The proposed method was successfully applied to three SC-APIs (hydrochlorothiazide, furosemide and sulfadiazine). Palladium was used as chemical modifier as well as hydrogen during the pyrolysis allowing the direct determination of As in the SC-APIs without interferences caused by gaseous sulfur species. Sample masses (hydrochlorothiazide) from 0.4 to 3 mg were used and calibration with aqueous standard solutions was feasible. The limit of quantification was 0.033 mg g-1 and the calibration ranged from 0.1 to 1.6 ng As. Recoveries for As solutions added directly to the solid samples were between 95 and 103%, showing a good accuracy. The method validation highlighted its robustness, since variation in pyrolysis and atomization temperatures, as well as in Pd and sample masses, did not change significantly the results. Additional experiments showed that this method can be applied to other SC-APIs (as e.g., furosemide and sulfadiazine). Arsenic concentration in hydrochlorothiazide samples ranged from 0.13 to 0.48 mg g-1, while in furosemide and sulfadiazine samples it was from 0.49 and 0.54 mg g-1, respectively. The use of DSS-GF AAS does not require previous sample digestion and As could be directly determined in the solid samples providing some advantages, as lower risks of contamination and analyte losses, good accuracy and limits of quantification.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2527-2616
Relation: https://seer.ufrgs.br/dar/article/view/89766/53381; https://doaj.org/toc/2527-2616
DOI: 10.22456/2527-2616.89766
Access URL: https://doaj.org/article/ccaf512edd724d0292a3ef291ec8c4ff
Accession Number: edsdoj.f512edd724d0292a3ef291ec8c4ff
Database: Directory of Open Access Journals
More Details
ISSN:25272616
DOI:10.22456/2527-2616.89766
Published in:Drug Analytical Research
Language:English